Predict your next investment

Sinovant Sciences company logo
HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Corporate Majority | Alive

About Sinovant Sciences

Sinovant Sciences is a Shanghai-based biopharmaceutical company dedicated to bringing innovative medicines to China and advancing Chinese biopharmaceutical innovation abroad. Sinovant has built a pipeline of 11 investigational biopharmaceutical products for Greater China and other Asian markets, including four therapies suitable for Phase 3 clinical trial application or registration in China. Sinovant's investigational therapies address several of China's greatest public health priorities, including liver cancer and drug-resistant bacterial infections.

Sinovant Sciences Headquarter Location

Shanghai, Shanghai,


Latest Sinovant Sciences News

Sinovant Says Antibiotic Effective for Pneumonia; Transfers China Rights to Sumitomo

May 27, 2021

publication date: May 27, 2021 Sinovant Sciences, a China adults with community acquired bacterial pneumonia (CABP). The trial showed lefamulin was non-inferior to IV/oral moxifloxacin in patients with CABP. In 2017, Sinovant acquired China Vienna China Suzhou Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sinovant Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sinovant Sciences is included in 2 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.



4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Sinovant Sciences Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sinovant Sciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.